These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Evaluation of the tolerability and efficacy of sodium polystyrene sulfonate for long-term management of hyperkalemia in patients with chronic kidney disease. Georgianos PI, Liampas I, Kyriakou A, Vaios V, Raptis V, Savvidis N, Sioulis A, Liakopoulos V, Balaskas EV, Zebekakis PE. Int Urol Nephrol; 2017 Dec; 49(12):2217-2221. PubMed ID: 29027620 [Abstract] [Full Text] [Related]
8. Necrosis of the gastrointestinal tract in uremic patients as a result of sodium polystyrene sulfonate (Kayexalate) in sorbitol: an underrecognized condition. Rashid A, Hamilton SR. Am J Surg Pathol; 1997 Jan; 21(1):60-9. PubMed ID: 8990142 [Abstract] [Full Text] [Related]
9. Sodium polystyrene sulfonate for the treatment of acute hyperkalemia: a retrospective study. Hagan AE, Farrington CA, Wall GC, Belz MM. Clin Nephrol; 2016 Jan; 85(1):38-43. PubMed ID: 26587776 [Abstract] [Full Text] [Related]
15. Colonic necrosis due to oral kayexalate in a critically-ill patient. Thomas A, James BR, Landsberg D. Am J Med Sci; 2009 Apr; 337(4):305-6. PubMed ID: 19365182 [Abstract] [Full Text] [Related]
17. Acute abdomen with colonic necrosis induced by Kayexalate-sorbitol. Dardik A, Moesinger RC, Efron G, Barbul A, Harrison MG. South Med J; 2000 May; 93(5):511-3. PubMed ID: 10832954 [Abstract] [Full Text] [Related]
18. Polysulfonate Resins in Hyperkalemia: A Systematic Review. Wong SWS, Zhang G, Norman P, Welihinda H, Wijeratne DT. Can J Kidney Health Dis; 2020 May; 7():2054358120965838. PubMed ID: 33240515 [Abstract] [Full Text] [Related]